Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative

Conclusions: We provide additional evidence that CCBs do not influence breast cancer risk in postmenopausal women. Impact: The results from this study, which includes strong control for potential confounding factors, cast doubt on increases in risk with CCBs. Cancer Epidemiol Biomarkers Prev; 26(8); 1345–8. ©2017 AACR.

http://cebp.aacrjournals.org/cgi/content/short/26/8/1345?rss=1

Source: Cancer Epidemiology Biomarkers and Prevention - August 1, 2017 Category: Cancer & Oncology Authors: Brasky, T. M., Krok-Schoen, J. L., Liu, J., Chlebowski, R. T., Freudenheim, J. L., Lavasani, S., Margolis, K. L., Qi, L., Reding, K. W., Shields, P. G., Simon, M. S., Wactawski-Wende, J., Wang, A., Womack, C., Manson, J. E. Tags: Null Results in Brief Source Type: research